510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K841245Substantially Equivalent

Enzygnost Antiherpes Simplex Virus

Behring Diagnostics, Inc., La Jolla CA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K841245 is the FDA 510(k) clearance record for ENZYGNOST ANTIHERPES SIMPLEX VIRUS, a class II device, cleared for Behring Diagnostics, Inc. on under FDA product code GQO (Antisera, Cf, Herpesvirus Hominis 1,2). FDA records list 145 510(k) clearances for Behring Diagnostics, Inc., from to . As of , FDA records show no recalls naming K841245.

Clearance record

Decision date
Received
(592 days to decision)
Product code
GQO Antisera, Cf, Herpesvirus Hominis 1,2
Regulation
21 CFR 866.3305
Device class
Class II
Review panel
Microbiology
Applicant
Behring Diagnostics, Inc.
Third party review
No

Clearances, product code GQO

Trailing 12 months

FDA records hold no clearances under product code GQO in the trailing twelve months.

FDA records show no clearances under product code GQO in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code GQO, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260